What is Stepan Co.'s earnings per share (EPS)?

Stepan Co. (SCL) reported diluted earnings per share of $2.05 for fiscal year 2025. This represents a -6.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stepan Co. (SCL) Financials

SCL

Trailing 12 months to June 30, 2026

Revenue $2.4B +7.6% YoY

Net Income -$2.7M -104.6% YoY

EPS (Diluted) -$0.12 -104.7% YoY

Free Cash Flow $36.6M +401.8% YoY

Market Cap $1.4B as of Oct 8, 2026

Price / Sales 0.6x on $2.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.2x on $1.2B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SCL SEC filings page.

Stepan Co. (SCL) reported $2.4B in revenue over the twelve months to Jun 30, 2026, up 7.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SCL FY2025 2026-10-03

Stepan has regained sales, but thin margins and heavy reinvestment keep cash returns modest.

FY2025 operating cash flow of $147.9M became only $25.4M of free cash flow after capital spending, so cash generation is positive but reinvestment-heavy. Free cash flow fell from $39.3M in FY2024 to $25.4M in FY2025, showing that earnings conversion depends heavily on the spending cycle, not just reported profit.

Leverage eased from 0.4x in FY2022 to 0.3x in FY2025, indicating equity grew faster than debt rather than expansion being funded mainly through borrowing. The current ratio was 1.3x in FY2025, below its 1.6x FY2022 level; the short-term cushion is thinner even as leverage improved.

Sales recovered to $2.3B in FY2025, but gross margin fell to 11.6%; the rebound did not restore product-level economics. Operating margin rose from 3.2% in FY2024 to 3.4% in FY2025, suggesting overhead control partly offset that pressure.

Financial Health Signals

Financial Health Score 39/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Stepan Co.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Stepan Co. has an operating margin of 3.4%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 47/100, indicating healthy but not exceptional operating efficiency. This is up from 3.2% the prior year.

Growth

Stepan Co.'s revenue grew 7.0% year-over-year to $2.3B, a solid pace of expansion. This earns a growth score of 31/100.

Leverage

Stepan Co. has a moderate D/E ratio of 0.27. This balance of debt and equity financing earns a leverage score of 47/100.

Liquidity

Stepan Co.'s current ratio of 1.29 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Stepan Co. generated $147.9M in operating cash flow, capex of $122.5M consumed most of it, leaving $25.4M in free cash flow. This results in a low score of 26/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Stepan Co.'s ROE of 3.8% shows moderate profitability relative to equity, earning a score of 48/100. This is down from 4.3% the prior year.

Altman Z-Score Grey Zone

2.71

Stepan Co. scores 2.71, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Stepan Co. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.15x

For every $1 of reported earnings, Stepan Co. generates $3.15 in operating cash flow ($147.9M OCF vs $46.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.55x

Stepan Co. earns $2.55 in operating income for every $1 of interest expense ($78.5M vs $30.8M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$684.1M

YoY+15.0%

QoQ+13.2%

5Y CAGR+2.8%

10Y CAGR+4.2%

Stepan Co. generated $684.1M in revenue in Q2 2026. This represents an increase of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 13.2%.

EBITDA

$68.1M

YoY+38.3%

QoQ+508.6%

5Y CAGR-3.1%

10Y CAGR+1.1%

Stepan Co.'s EBITDA was $68.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 38.3% from the same quarter a year earlier. Against the prior quarter it is up 508.6%.

Net Income

$22.9M

YoY+102.0%

QoQ+155.3%

5Y CAGR-11.9%

10Y CAGR-2.2%

Stepan Co. reported $22.9M in net income in Q2 2026. This represents an increase of 102.0% from the same quarter a year earlier. Against the prior quarter it is up 155.3%.

EPS (Diluted)

$1.00

YoY+100.0%

QoQ+155.2%

5Y CAGR-11.6%

10Y CAGR-2.1%

Stepan Co. earned $1.00 per diluted share (EPS) in Q2 2026. This represents an increase of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 155.2%.

Cash & Balance Sheet

Free Cash Flow

-$15.0M

YoY-4.4%

QoQ-7.8%

Stepan Co. recorded an outflow of $15.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 4.4% from the same quarter a year earlier. Against the prior quarter it is down 7.8%.

Cash & Debt

$113.7M

YoY+27.9%

QoQ-19.2%

5Y CAGR-2.2%

10Y CAGR-5.0%

Stepan Co. held $113.7M in cash against $244.1M in long-term debt as of Q2 2026.

Dividends Per Share

$0.40

YoY+2.6%

QoQ0.0%

5Y CAGR+5.3%

Stepan Co. paid $0.40 per share in dividends in Q2 2026. This represents an increase of 2.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

23M

YoY+0.5%

QoQ+0.1%

5Y CAGR+0.2%

10Y CAGR+0.2%

Stepan Co. had 23M shares outstanding in Q2 2026. This represents an increase of 0.5% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin

14.6%

YoY+2.5pp

QoQ+3.9pp

5Y change-4.1pp

10Y change-5.8pp

Stepan Co.'s gross margin was 14.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.9 percentage points.

Operating Margin

5.4%

YoY+2.4pp

QoQ+13.7pp

5Y change-4.1pp

10Y change-4.0pp

Stepan Co.'s operating margin was 5.4% in Q2 2026, reflecting core business profitability. This is up 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.7 percentage points.

Net Margin

3.4%

YoY+1.4pp

QoQ+10.2pp

5Y change-3.9pp

10Y change-2.9pp

Stepan Co.'s net profit margin was 3.4% in Q2 2026, showing the share of revenue converted to profit. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.2 percentage points.

Return on Equity

1.9%

YoY+1.0pp

QoQ+5.4pp

5Y change-2.2pp

10Y change-2.7pp

Stepan Co.'s ROE was 1.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.4 percentage points.

Capital Allocation

Capital Expenditures

$23.4M

YoY-8.6%

QoQ-24.2%

5Y CAGR-8.9%

10Y CAGR+0.9%

Stepan Co. invested $23.4M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 8.6% from the same quarter a year earlier. Against the prior quarter it is down 24.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

SCL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.4B	$2.3B+7.0%	$2.2B-6.3%	$2.3B-16.1%	$2.8B+18.2%	$2.3B+25.5%	$1.9B+0.6%	$1.9B-6.8%	$2.0B+3.6%	$1.9B+9.0%	$1.8B-0.6%	$1.8B-7.8%	$1.9B+2.5%	$1.9B+4.3%	$1.8B-2.1%	$1.8B
Cost of Revenue	$2.1B	$2.1B+8.1%	$1.9B-6.8%	$2.0B-12.7%	$2.3B+20.3%	$2.0B+31.2%	$1.5B-2.2%	$1.5B-8.2%	$1.7B+4.8%	$1.6B+10.6%	$1.4B-2.8%	$1.5B-12.5%	$1.7B+4.9%	$1.6B+5.7%	$1.5B-4.7%	$1.6B
Gross Profit	$287.4M	$269.9M-0.9%	$272.2M-1.9%	$277.6M-35.0%	$427.1M+7.9%	$395.8M+3.2%	$383.6M+12.9%	$339.7M+0.1%	$339.3M-2.0%	$346.2M+2.0%	$339.3M+10.1%	$308.2M+23.5%	$249.6M-11.4%	$281.7M-3.4%	$291.6M+14.1%	$255.6M
R&D Expenses	N/A	$34.8M+3.7%	$33.5M-6.1%	$35.7M-12.6%	$40.9M+5.5%	$38.8M+7.7%	$36.0M+5.4%	$34.1M+1.8%	$33.5M+1.1%	$33.2M-4.8%	$34.9M+15.0%	$30.3M+11.3%	$27.2M-5.4%	$28.8M+2.7%	$28.0M+11.6%	$25.1M
SG&A Expenses	$92.1M	$90.8M-7.6%	$98.3M+5.4%	$93.2M-8.8%	$102.2M+10.0%	$92.9M+6.3%	$87.4M+5.8%	$82.6M+4.2%	$79.2M+4.8%	$75.6M+1.0%	$74.9M-1.5%	$76.0M+14.3%	$66.5M+7.4%	$62.0M-3.2%	$64.0M+26.0%	$50.8M
Operating Income	$19.9M	$78.5M+11.4%	$70.5M+20.2%	$58.6M-71.7%	$207.3M+21.4%	$170.8M-0.4%	$171.5M+34.8%	$127.3M-14.7%	$149.3M-3.6%	$154.8M+21.1%	$127.8M+4.1%	$122.8M+35.4%	$90.7M-16.9%	$109.2M-15.2%	$128.7M+8.7%	$118.5M
EBITDA	N/A	$204.6M+12.0%	$182.7M+11.4%	$164.0M-45.7%	$302.0M+15.4%	$261.7M+3.3%	$253.4M+23.0%	$206.0M-10.6%	$230.4M-1.5%	$233.9M+15.3%	$202.8M+6.9%	$189.8M+22.8%	$154.5M-6.7%	$165.6M-8.0%	$180.0M+8.7%	$165.6M
Interest Expense	$31.9M	$30.8M-6.8%	$33.0M+12.5%	$29.4M+64.5%	$17.9M+76.0%	$10.1M+2.9%	$9.9M-22.6%	$12.7M-4.6%	$13.4M-7.4%	$14.4M+9.3%	$13.2M-9.1%	$14.5M+27.0%	$11.4M+10.5%	$10.4M+7.9%	$9.6M+5.5%	$9.1M
Income Tax	$2.2M	$13.0M+29.2%	$10.1M+23.0%	$8.2M-80.3%	$41.5M+19.9%	$34.6M-20.2%	$43.4M+90.4%	$22.8M-14.5%	$26.7M-42.2%	$46.1M+67.1%	$27.6M+3.0%	$26.8M+45.3%	$18.5M-20.8%	$23.3M-35.4%	$36.0M+11.6%	$32.3M
Net Income	-$2.7M	$46.9M-6.9%	$50.4M+25.3%	$40.2M-72.7%	$147.2M+6.8%	$137.8M+8.7%	$126.8M+22.9%	$103.1M-7.2%	$111.1M+10.3%	$100.8M+16.9%	$86.2M+13.5%	$76.0M+33.0%	$57.1M-21.6%	$72.8M-8.3%	$79.4M+10.3%	$72.0M
EPS (Basic)	N/A	$2.05-7.2%	$2.21+24.9%	$1.77-72.6%	$6.46+7.5%	$6.01+8.9%	$5.52+23.5%	$4.47-7.5%	$4.83+10.0%	$4.39+16.1%	$3.78+13.2%	$3.34+33.1%	$2.51-22.0%	$3.22-13.2%	$3.71+7.8%	$3.44
EPS (Diluted)	-$0.12	$2.05-6.8%	$2.20+25.7%	$1.75-72.6%	$6.38+7.8%	$5.92+8.6%	$5.45+23.3%	$4.42-7.1%	$4.76+10.4%	$4.31+15.5%	$3.73+12.3%	$3.32+33.3%	$2.49-21.7%	$3.18-8.9%	$3.49	$3.21
Diluted Shares (Avg)	N/A	23M-0.2%	23M-0.1%	23M-0.5%	23M-1.0%	23M+0.1%	23M-0.3%	23M0.0%	23M-0.2%	23M+1.2%	23M+1.0%	23M-0.3%	23M0.0%	23M+0.9%	23M	22M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$684.1M+15.0%	$604.5M+1.9%	$553.9M+5.4%	$590.3M+7.9%	$594.7M+6.9%	$593.3M+7.6%	$525.6M-1.2%	$546.8M-2.7%
Cost of Revenue	$584.1M+11.7%	$539.7M+4.2%	$502.4M+7.1%	$519.3M+10.2%	$522.8M+7.4%	$517.8M+7.6%	$468.9M+0.7%	$471.2M-4.0%
Gross Profit	$100.0M+39.1%	$64.9M-14.1%	$51.5M-9.1%	$71.0M-6.2%	$71.9M+3.4%	$75.5M+7.4%	$56.7M-14.6%	$75.7M+6.2%
SG&A Expenses	$24.2M+6.1%	$21.3M-0.5%	$23.7M-4.3%	$22.9M-12.9%	$22.8M-7.2%	$21.4M-5.6%	$24.8M-1.2%	$26.3M+14.6%
Operating Income	$37.2M+107.1%	-$49.6M-275.4%	$10.5M+36.5%	$21.8M-9.0%	$18.0M-3.8%	$28.3M+40.3%	$7.7M+3245.7%	$23.9M+22.7%
EBITDA	$68.1M+38.3%	-$16.7M-129.0%	$43.2M+19.4%	$54.5M+4.9%	$49.3M+5.5%	$57.6M+20.5%	$36.2M+32.9%	$52.0M+13.5%
Interest Expense	$5.7M+3.6%	$5.0M+21.4%	$14.3M-39.4%	$6.8M+88.2%	$5.5M+106.1%	$4.1M+34.4%	$23.7M+20.3%	$3.6M+21.2%
Income Tax	$9.6M+294.2%	-$13.1M-364.1%	-$65K+92.7%	$5.7M+348.0%	$2.4M-68.2%	$5.0M-11.0%	-$894K+63.8%	-$2.3M-170.0%
Net Income	$22.9M+102.0%	-$41.4M-310.1%	$5.0M+49.4%	$10.8M-54.1%	$11.3M+19.1%	$19.7M+41.9%	$3.4M+380.8%	$23.6M+87.8%
EPS (Basic)	$1.00+100.0%	-$1.81-310.5%	$0.22+46.7%	$0.47-54.4%	$0.50+19.0%	$0.86+41.0%	$0.15+400.0%	$1.03+87.3%
EPS (Diluted)	$1.00+100.0%	-$1.81-310.5%	$0.22+46.7%	$0.47-54.4%	$0.50+19.0%	$0.86+41.0%	$0.15+400.0%	$1.03+87.3%
Diluted Shares (Avg)	23M+0.2%	23M0.0%	N/A	23M-0.1%	23M-0.2%	23M-0.3%	N/A	23M0.0%

Not reported in any period shown, so not listed: R&D Expenses.

SCL Balance Sheet

SCL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$2.4B+2.3%	$2.3B-2.5%	$2.4B-2.9%	$2.4B+17.8%	$2.1B+17.9%	$1.8B+11.0%	$1.6B+4.3%	$1.5B+0.8%	$1.5B+11.0%	$1.4B+9.3%	$1.2B+6.6%	$1.2B-0.4%	$1.2B+18.4%	$985.5M+9.4%	$901.1M
Current Assets	$859.0M+6.0%	$810.4M-4.9%	$851.9M-18.5%	$1.0B+14.4%	$913.4M+0.9%	$905.7M+10.6%	$818.8M-1.8%	$833.9M+5.7%	$788.7M+15.1%	$685.5M+10.6%	$619.6M+7.6%	$575.6M-5.4%	$608.5M+16.3%	$523.1M+9.0%	$479.7M
Cash & Equivalents	$132.7M+33.1%	$99.7M-23.2%	$129.8M-25.3%	$173.8M+9.1%	$159.2M-54.5%	$349.9M+11.0%	$315.4M+5.1%	$300.2M+0.4%	$298.9M+32.4%	$225.7M+28.2%	$176.1M+106.7%	$85.2M-36.1%	$133.3M+73.5%	$76.9M-8.6%	$84.1M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$298.8M+3.5%	$288.7M+8.7%	$265.6M-34.0%	$402.5M+31.7%	$305.5M+39.7%	$218.8M+7.4%	$203.6M-12.0%	$231.5M+34.0%	$172.7M-0.5%	$173.7M+1.9%	$170.4M-7.0%	$183.2M+6.3%	$172.4M+6.4%	$162.0M+45.7%	$111.2M
Long-Term Investments	$21.3M-16.8%	$25.6M-4.6%	$26.8M+15.1%	$23.3M-32.5%	$34.5M+12.5%	$30.7M+8.6%	$28.2M+12.5%	$25.1M-11.3%	$28.3M+17.5%	$24.1M+15.0%	$20.9M+3.4%	$20.2M+10.4%	$18.3M+29.9%	$14.1M+13.1%	$12.5M
Goodwill	$92.6M+1.3%	$91.4M-6.2%	$97.4M+1.6%	$95.9M-1.3%	$97.2M+247.4%	$28.0M+7.2%	$26.1M+13.6%	$23.0M-8.6%	$25.1M-0.8%	$25.3M+124.7%	$11.3M-2.1%	$11.5M-1.9%	$11.7M+62.9%	$7.2M+2.8%	$7.0M
Total Liabilities	$1.1B-1.9%	$1.1B-1.1%	$1.1B-9.5%	$1.3B+27.8%	$991.4M+29.5%	$765.6M+11.4%	$687.6M-2.8%	$707.2M-7.3%	$762.8M+6.0%	$719.3M+5.6%	$681.4M+8.8%	$626.5M+1.9%	$614.9M+21.4%	$506.5M+1.3%	$499.9M
Current Liabilities	$666.5M-0.4%	$669.0M+10.1%	$607.9M-9.4%	$670.6M+34.0%	$500.5M+20.1%	$416.6M+22.8%	$339.1M+0.2%	$338.6M+5.7%	$320.3M+7.7%	$297.3M+22.2%	$243.2M-2.5%	$249.5M-7.2%	$269.0M+8.8%	$247.2M+6.0%	$233.2M
Non-Current Liabilities	$447.2M-4.0%	$465.7M-13.6%	$539.0M-9.6%	$596.5M+21.5%	$490.9M+40.6%	$349.1M+0.2%	$348.5M-5.5%	$368.6M-16.7%	$442.5M+4.9%	$422.0M-3.7%	$438.2M+16.2%	$377.0M+9.0%	$345.9M+33.4%	$259.3M-2.8%	$266.7M
Long-Term Debt	$341.0M+2.5%	$332.6M-17.1%	$401.2M-11.8%	$455.0M+40.9%	$322.9M+100.8%	$160.8M-19.0%	$198.5M-16.9%	$239.0M-10.9%	$268.3M-7.1%	$288.9M-7.6%	$312.5M+26.6%	$246.9M+5.0%	$235.2M+57.3%	$149.6M-9.3%	$165.0M
Total Equity	$1.2B+6.3%	$1.2B-3.8%	$1.2B+4.3%	$1.2B+8.6%	$1.1B+8.9%	$986.7M+10.6%	$891.8M+10.4%	$807.4M+9.1%	$740.1M+16.6%	$634.6M+13.9%	$557.0M+4.0%	$535.5M-3.0%	$552.3M+15.3%	$479.0M+19.4%	$401.2M
Retained Earnings	$1.3B+0.9%	$1.3B+1.3%	$1.3B+0.6%	$1.3B+10.3%	$1.1B+10.7%	$1.0B+11.0%	$922.5M+10.2%	$837.1M+16.0%	$721.7M+11.2%	$649.1M+11.9%	$580.2M+11.5%	$520.5M+8.7%	$478.8M+13.9%	$420.5M+14.8%	$366.3M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$2.4B-1.0%	$2.3B-2.4%	$2.4B+2.3%	$2.4B+0.8%	$2.4B+2.9%	$2.4B+0.7%	$2.3B-2.5%	$2.4B+3.4%
Current Assets	$974.8M+7.6%	$906.2M+1.0%	$859.0M+6.0%	$920.6M+0.3%	$906.1M+4.5%	$897.2M+3.1%	$810.4M-4.9%	$918.2M+8.1%
Cash & Equivalents	$113.7M+27.9%	$140.8M+31.0%	$132.7M+33.1%	$118.5M-19.5%	$88.9M-28.7%	$107.5M-14.5%	$99.7M-23.2%	$147.3M+39.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$324.5M-1.5%	$289.0M-6.6%	$298.8M+3.5%	$324.3M+9.3%	$329.5M+23.9%	$309.3M+20.3%	$288.7M+8.7%	$296.7M+4.3%
Long-Term Investments	$14.5M-26.6%	$13.3M-30.0%	$21.3M-16.8%	$20.8M-17.1%	$19.8M-17.9%	$19.0M-19.1%	$25.6M-4.6%	$25.1M+2.4%
Goodwill	$91.7M-7.2%	$92.3M-1.8%	$92.6M+1.3%	$99.0M+3.2%	$98.9M+4.8%	$94.0M-2.4%	$91.4M-6.2%	$95.9M-0.7%
Total Liabilities	$1.2B+0.5%	$1.1B-4.1%	$1.1B-1.9%	$1.2B-0.7%	$1.2B+1.6%	$1.2B+2.6%	$1.1B-1.1%	$1.2B+5.6%
Current Liabilities	$847.0M+25.9%	$720.5M-2.6%	$666.5M-0.4%	$709.4M-1.7%	$673.0M+2.7%	$739.5M+17.6%	$669.0M+10.1%	$721.3M+23.9%
Non-Current Liabilities	$333.6M-33.5%	$419.9M-6.6%	$447.2M-4.0%	$476.2M+0.6%	$501.4M+0.1%	$449.7M-15.1%	$465.7M-13.6%	$473.1M-13.8%
Long-Term Debt	$244.1M-36.3%	$328.4M-0.7%	$341.0M+2.5%	$357.1M+2.4%	$383.2M+2.3%	$330.8M-17.3%	$332.6M-17.1%	$348.7M-17.5%
Total Equity	$1.2B-2.4%	$1.2B-0.6%	$1.2B+6.3%	$1.2B+2.2%	$1.2B+4.1%	$1.2B-1.2%	$1.2B-3.8%	$1.2B+1.4%
Retained Earnings	$1.2B-3.0%	$1.2B-3.9%	$1.3B+0.9%	$1.3B+0.8%	$1.3B+1.9%	$1.3B+1.7%	$1.3B+1.3%	$1.3B+1.0%

Not reported in any period shown, so not listed: Accounts Receivable.

SCL Cash Flow Statement

SCL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$155.0M	$147.9M-8.7%	$162.1M-7.3%	$174.9M+8.8%	$160.8M+122.9%	$72.1M-69.3%	$235.2M+7.7%	$218.4M+27.6%	$171.1M-13.9%	$198.9M-6.3%	$212.2M+15.5%	$183.7M+122.4%	$82.6M-45.1%	$150.3M+37.9%	$109.0M+40.8%	$77.4M
Depreciation & Amortization	N/A	$126.0M+12.3%	$112.2M+6.5%	$105.3M+11.3%	$94.7M+4.2%	$90.9M+11.0%	$81.9M+4.0%	$78.7M-3.0%	$81.1M+2.6%	$79.0M+5.4%	$75.0M+11.9%	$67.0M+5.0%	$63.8M+13.1%	$56.4M+10.0%	$51.3M+8.9%	$47.1M
Stock-Based Compensation	N/A	$6.0M+12.2%	$5.3M-6.9%	$5.7M-58.6%	$13.9M+18.2%	$11.7M+16.2%	$10.1M+13.6%	$8.9M+29.8%	$6.8M-4.4%	$7.2M-43.3%	$12.6M+188.5%	$4.4M+6532.4%	-$68K-102.4%	$2.8M-10.9%	$3.1M-15.1%	$3.7M
Capital Expenditures	$118.5M	$122.5M-0.2%	$122.8M-52.8%	$260.3M-13.7%	$301.6M+55.1%	$194.5M+54.6%	$125.8M+19.2%	$105.6M+21.8%	$86.6M+10.2%	$78.6M-23.7%	$103.1M-13.6%	$119.3M+17.2%	$101.8M+9.6%	$92.9M+11.7%	$83.2M0.0%	$83.2M
Free Cash Flow	$36.6M	$25.4M-35.4%	$39.3M+146.0%	-$85.5M+39.3%	-$140.8M-15.1%	-$122.3M-211.8%	$109.4M-3.0%	$112.9M+33.6%	$84.5M-29.7%	$120.3M+10.2%	$109.1M+69.5%	$64.4M+434.8%	-$19.2M-133.5%	$57.4M+122.6%	$25.8M+545.8%	-$5.8M
Investing Cash Flow	-$83.9M	-$89.0M+23.9%	-$116.9M+54.8%	-$258.7M+16.0%	-$308.1M+18.2%	-$376.8M-171.0%	-$139.0M-23.4%	-$112.7M-4.5%	-$107.8M-30.4%	-$82.7M+36.7%	-$130.5M	N/A	N/A	-$167.6M-91.6%	-$87.4M+13.7%	-$101.4M
Financing Cash Flow	-$47.5M	-$35.4M+45.1%	-$64.5M-293.8%	$33.3M-80.0%	$166.2M+41.7%	$117.3M+280.7%	-$64.9M+28.2%	-$90.5M-75.2%	-$51.6M-2.3%	-$50.5M-69.6%	-$29.8M	N/A	N/A	$76.3M+358.7%	-$29.5M-1300.9%	-$2.1M
Dividends Paid	$35.6M	$35.0M+3.2%	$34.0M+3.3%	$32.9M+7.5%	$30.6M+8.9%	$28.1M+10.5%	$25.4M+10.0%	$23.1M+10.7%	$20.9M+10.3%	$18.9M+9.1%	$17.3M+6.3%	$16.3M+5.9%	$15.4M+6.3%	$14.5M+13.5%	$12.8M+10.8%	$11.5M
Share Buybacks	N/A	N/A	N/A	N/A	$24.9M+47.0%	$17.0M+11.3%	$15.3M+15.7%	$13.2M-14.9%	$15.5M+158.3%	$6.0M+149.2%	$2.4M+20.4%	$2.0M-74.8%	$7.9M+248.3%	$2.3M+8.4%	$2.1M+39.1%	$1.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$8.4M-25.3%	$16.9M+143.9%	$60.0M-12.1%	$69.8M+207.1%	$11.2M-62.1%	$6.9M-83.3%	$68.3M-1.0%	$22.7M-67.6%
Depreciation & Amortization	$30.9M-1.2%	$32.9M+12.6%	$32.7M+14.8%	$32.7M+16.7%	$31.3M+11.7%	$29.3M+6.0%	$28.5M+5.5%	$28.1M+6.7%
Stock-Based Compensation	$2.1M+25.9%	$1.5M+8.8%	N/A	$1.4M-9.5%	$1.7M+8.0%	$1.4M+0.7%	N/A	$1.6M+2.0%
Capital Expenditures	$23.4M-8.6%	$30.9M-5.7%	$34.6M-4.4%	$29.6M+10.7%	$25.6M-13.8%	$32.7M+8.6%	$36.2M-22.5%	$26.7M-50.3%
Free Cash Flow	-$15.0M-4.4%	-$14.0M+45.9%	$25.4M-20.9%	$40.2M+1106.7%	-$14.4M-6825.5%	-$25.8M-326.4%	$32.1M+44.3%	-$4.0M-124.4%
Investing Cash Flow	-$23.4M+6.6%	-$22.9M+13.3%	-$8.0M+77.8%	-$29.6M-10.7%	-$25.1M+15.4%	-$26.4M-8.2%	-$36.2M+22.5%	-$26.7M+50.3%
Financing Cash Flow	-$12.4M-30.5%	$13.6M-40.2%	-$37.7M+47.2%	-$11.0M-148.0%	-$9.5M-338.8%	$22.8M+213.9%	-$71.4M-2030.9%	$22.9M+155.5%
Dividends Paid	$9.0M+3.2%	$9.0M+3.2%	$8.9M+3.2%	$8.7M+3.2%	$8.7M+3.2%	$8.7M+3.1%	$8.7M+3.2%	$8.4M+3.4%

Not reported in any period shown, so not listed: Share Buybacks.

SCL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SCL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	11.6%-0.9pp	12.5%+0.5pp	11.9%-3.5pp	15.4%-1.5pp	16.9%-3.7pp	20.5%+2.2pp	18.3%+1.3pp	17.0%-1.0pp	18.0%-1.2pp	19.2%+1.9pp	17.3%+4.4pp	13.0%-2.0pp	15.0%-1.2pp	16.2%+2.3pp	13.9%
Operating Margin	3.4%+0.1pp	3.2%+0.7pp	2.5%-5.0pp	7.5%+0.2pp	7.3%-1.9pp	9.2%+2.3pp	6.9%-0.6pp	7.5%-0.6pp	8.0%+0.8pp	7.2%+0.3pp	6.9%+2.2pp	4.7%-1.1pp	5.8%-1.3pp	7.1%+0.7pp	6.4%
Net Margin	2.0%-0.3pp	2.3%+0.6pp	1.7%-3.6pp	5.3%-0.6pp	5.9%-0.9pp	6.8%+1.2pp	5.5%0.0pp	5.6%+0.3pp	5.2%+0.3pp	4.9%+0.6pp	4.3%+1.3pp	3.0%-0.9pp	3.9%-0.5pp	4.4%+0.5pp	3.9%
Return on Equity	3.8%-0.5pp	4.3%+1.0pp	3.3%-9.3pp	12.6%-0.2pp	12.8%0.0pp	12.8%+1.3pp	11.6%-2.2pp	13.8%+0.1pp	13.6%0.0pp	13.6%-0.1pp	13.6%+3.0pp	10.7%-2.5pp	13.2%-3.4pp	16.6%-1.4pp	17.9%
Return on Assets	2.0%-0.2pp	2.2%+0.5pp	1.7%-4.3pp	6.0%-0.6pp	6.7%-0.6pp	7.2%+0.7pp	6.5%-0.8pp	7.3%+0.6pp	6.7%+0.3pp	6.4%+0.2pp	6.1%+1.2pp	4.9%-1.3pp	6.2%-1.8pp	8.1%+0.1pp	8.0%
Current Ratio	1.29+0.1x	1.21-0.2x	1.40-0.2x	1.56-0.3x	1.82-0.3x	2.17-0.2x	2.410.0x	2.460.0x	2.46+0.2x	2.31-0.2x	2.55+0.2x	2.310.0x	2.26+0.1x	2.12+0.1x	2.06
Debt-to-Equity	0.270.0x	0.280.0x	0.33-0.1x	0.39+0.1x	0.30+0.1x	0.16-0.1x	0.22-0.1x	0.30-0.1x	0.36-0.1x	0.46-0.1x	0.56+0.1x	0.460.0x	0.43+0.1x	0.31-0.1x	0.41
Asset Turnover	0.990.0x	0.950.0x	0.98-0.2x	1.140.0x	1.14+0.1x	1.07-0.1x	1.18-0.1x	1.320.0x	1.280.0x	1.30-0.1x	1.43-0.2x	1.660.0x	1.61-0.2x	1.83-0.2x	2.05
FCF Margin	1.1%-0.7pp	1.8%+5.5pp	-3.7%+1.4pp	-5.1%+0.1pp	-5.2%-11.1pp	5.9%-0.2pp	6.1%+1.8pp	4.2%-2.0pp	6.3%+0.1pp	6.2%+2.6pp	3.6%+4.6pp	-1.0%-4.0pp	3.0%+1.6pp	1.4%+1.7pp	-0.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	14.6%+2.5pp	10.7%-2.0pp	9.3%-1.5pp	12.0%-1.8pp	12.1%-0.4pp	12.7%0.0pp	10.8%-1.7pp	13.8%+1.2pp
Operating Margin	5.4%+2.4pp	-8.2%-13.0pp	1.9%+0.4pp	3.7%-0.7pp	3.0%-0.3pp	4.8%+1.1pp	1.5%+1.4pp	4.4%+0.9pp
Net Margin	3.4%+1.4pp	-6.9%-10.2pp	0.9%+0.3pp	1.8%-2.5pp	1.9%+0.2pp	3.3%+0.8pp	0.6%+0.9pp	4.3%+2.1pp
Return on Equity	1.9%+1.0pp	-3.5%-5.1pp	0.4%+0.1pp	0.9%-1.1pp	0.9%+0.1pp	1.6%+0.5pp	0.3%+0.4pp	1.9%+0.9pp
Return on Assets	1.0%+0.5pp	-1.8%-2.6pp	0.2%+0.1pp	0.4%-0.5pp	0.5%+0.1pp	0.8%+0.2pp	0.1%+0.2pp	1.0%+0.4pp
Current Ratio	1.15-0.2x	1.260.0x	1.29+0.1x	1.300.0x	1.350.0x	1.21-0.2x	1.21-0.2x	1.27-0.2x
Debt-to-Equity	0.20-0.1x	0.280.0x	0.270.0x	0.290.0x	0.310.0x	0.28-0.1x	0.280.0x	0.29-0.1x
Asset Turnover	0.290.0x	0.260.0x	0.230.0x	0.240.0x	0.250.0x	0.250.0x	0.230.0x	0.230.0x
FCF Margin	-2.2%+0.2pp	-2.3%+2.0pp	4.6%-1.5pp	6.8%+7.5pp	-2.4%-2.4pp	-4.3%-6.4pp	6.1%+1.9pp	-0.7%-3.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Stepan Co. SCL	FY2025	$2.3B	$46.9M	2.0%	$1.4B	39/100
Ecovyst Inc. ECVT	FY2025	$723.5M	-$71.1M	-9.8%	$1.1B	64/100
Oil-Dri Corporation of America ODC	FY2025	$485.6M	$54.0M	11.1%	$1.3B	66/100
Kronos Worldwide, Inc. KRO	FY2025	$1.9B	-$110.9M	-6.0%	$895.5M	36/100
Mativ Holdings, Inc. MATV	FY2025	$2.0B	-$337.4M	-17.0%	$657.9M	34/100
Koppers Holdings, Inc. KOP	FY2025	$1.9B	$56.0M	3.0%	$829.8M	48/100

Where Stepan Co. Ranks

Frequently Asked Questions

What is Stepan Co.'s annual revenue?

Stepan Co. (SCL) reported $2.3B in total revenue for fiscal year 2025. This represents a 7.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Stepan Co.'s revenue growing?

Stepan Co. (SCL) revenue grew by 7.0% year-over-year, from $2.2B to $2.3B in fiscal year 2025.

Is Stepan Co. profitable?

Yes, Stepan Co. (SCL) reported a net income of $46.9M in fiscal year 2025, with a net profit margin of 2.0%.

What is Stepan Co.'s EBITDA?

Stepan Co. (SCL) had EBITDA of $204.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Stepan Co. have?

As of fiscal year 2025, Stepan Co. (SCL) had $132.7M in cash and equivalents against $341.0M in long-term debt.

What is Stepan Co.'s gross margin?

Stepan Co. (SCL) had a gross margin of 11.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Stepan Co.'s operating margin?

Stepan Co. (SCL) had an operating margin of 3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Stepan Co.'s net profit margin?

Stepan Co. (SCL) had a net profit margin of 2.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Stepan Co. pay dividends?

Yes, Stepan Co. (SCL) paid $1.55 per share in dividends during fiscal year 2025.

What is Stepan Co.'s return on equity (ROE)?

Stepan Co. (SCL) has a return on equity of 3.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Stepan Co.'s free cash flow?

Stepan Co. (SCL) generated $25.4M in free cash flow during fiscal year 2025. This represents a -35.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Stepan Co.'s operating cash flow?

Stepan Co. (SCL) generated $147.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Stepan Co.'s total assets?

Stepan Co. (SCL) had $2.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Stepan Co.'s capital expenditures?

Stepan Co. (SCL) invested $122.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Stepan Co. spend on research and development?

Stepan Co. (SCL) invested $34.8M in research and development during fiscal year 2025.

How many shares does Stepan Co. have outstanding?

Stepan Co. (SCL) had 23M shares outstanding as of fiscal year 2025.

What is Stepan Co.'s current ratio?

Stepan Co. (SCL) had a current ratio of 1.29 as of fiscal year 2025, which is considered adequate.

What is Stepan Co.'s debt-to-equity ratio?

Stepan Co. (SCL) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Stepan Co.'s return on assets (ROA)?

Stepan Co. (SCL) had a return on assets of 2.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Stepan Co.'s P/E ratio?

Stepan Co. (SCL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.4B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Stepan Co.'s price-to-sales ratio?

Stepan Co. (SCL) trades at 0.6x sales, its market capitalization divided by revenue of $2.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Stepan Co.'s Altman Z-Score?

Stepan Co. (SCL) has an Altman Z-Score of 2.71, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Stepan Co.'s Piotroski F-Score?

Stepan Co. (SCL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Stepan Co.'s earnings high quality?

Stepan Co. (SCL) has an earnings quality ratio of 3.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Stepan Co. cover its interest payments?

Stepan Co. (SCL) has an interest coverage ratio of 2.55x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Stepan Co.?

Stepan Co. (SCL) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.